Cargando…
罕见肿瘤新药研发的思考
In recent years, China's anti-tumor drugs has shown a continuous growth trend, and the activity of anti-tumor research and development in China accounts for a higher proportion in the world. However, further analysis of research and development hotspots show that the research and development of...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346156/ https://www.ncbi.nlm.nih.gov/pubmed/35899439 http://dx.doi.org/10.3779/j.issn.1009-3419.2022.101.26 |
Ejemplares similares
-
境外授权许可引进抗肿瘤新药临床研发策略的审评考虑
Publicado: (2022) -
研究者发起的临床研究用于支持新药研发面临的挑战
Publicado: (2022) -
MUC16:肿瘤治疗新靶点
Publicado: (2022) -
核酸干扰药物在抗肿瘤领域的机遇和挑战
Publicado: (2022) -
非小细胞肺癌新辅助免疫治疗进展
Publicado: (2022)